SANTA MONICA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (?Opiant?) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2019, after the market close, and will host a corporate update conference call and webcast on Wednesday, March 4, at 4:30 p.m. Eastern Time.
News Ticker
- [ June 10, 2023 ] Graduating senior lights the path for transfer students – through her award-winning research and mentoring Los Angeles Biotech News
- [ June 10, 2023 ] Postdoctoral Scientist – Karsh Division of Gastroenterology and Hepatology – Part-Time – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
- [ June 10, 2023 ] Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more Los Angeles Biotech News
- [ June 10, 2023 ] Scientist, Cell Biology – Thermo Fisher Scientific – West Hills, CA Los Angeles Biotech Jobs
- [ June 10, 2023 ] Security Officer – Biotechnology Company – Allied Universal® – Oceanside, CA Los Angeles Biotech Jobs
Copyright © 2021 Biotech Networks, LLC
